April 2022: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

Apr 29, 2022

Article and Study Summary: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis Published in: New England Journal of Medicine 2022;386(12):1109-1120 https://www.nejm.org/doi/full/10.1056/NEJMoa2111904 Authors: Jarvis JN, Lawrence DS, Meya DB, et...

February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children

Feb 28, 2022

Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...

January 2022: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis

Jan 31, 2022

Article and Study Summary: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. Published in: New England Journal of Medicine. 2021;385(26):2441-2450 https://www.nejm.org/doi/full/10.1056/NEJMoa2105470 Authors: Cattamanchi A, Reza TF,...

July/August 2021: Comparing Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir for second-line HIV treatment: Results of the NADIA Trial in Uganda, Kenya, and Zimbabwe

Aug 27, 2021

Article and Study Summary: Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. Published in: N Engl J Med 2021;385(4):330-341. https://www.nejm.org/doi/full/10.1056/NEJMoa2101609 Authors: Paton NI, Musaazi J, Kityo C, et al. Summary:...

Special Webinar (Archived Recording) — Population Surveys: Measuring and Informing the HIV Response

Jul 8, 2021

RECORDED: Thursday, July 1, 2021, 9:00 – 10:30 a.m. ET ACCESS THE RECORDING ACCESS THE SLIDES, including Q&A On Thursday, July 1, 2021, ICAP at Columbia University hosted a webinar to discuss population surveys and how their findings provide critical information...

Uganda